Literature DB >> 15683604

Adipocytokines: emerging therapeutic targets.

Yuji Matsuzawa1.   

Abstract

Recently, adipocytes have been shown to be recognized as endocrine cells that secrete a variety of bioactive substances known as adipocytokines. Among adipocytokines, adiponectin, a newly found adipose tissue-specific collagen-like protein, has been noted as an important antiatherogenic and antidiabetic protein. The function of adipocytes might be regulated dynamically by nutritional state. Visceral fat accumulation causes dysfunction of adipocytes and results in the development of a variety of metabolic and circulatory diseases through the abnormal secretion of adipocytokines. In this review, the importance of adipocytokines, including adiponectin, is discussed with respect to atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683604     DOI: 10.1007/s11883-005-0076-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  10 in total

Review 1.  Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience.

Authors:  Y Matsuzawa
Journal:  Diabetes Metab Rev       Date:  1997-03

2.  The hormone resistin links obesity to diabetes.

Authors:  C M Steppan; S T Bailey; S Bhat; E J Brown; R R Banerjee; C M Wright; H R Patel; R S Ahima; M A Lazar
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

3.  Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.

Authors:  I Shimomura; T Funahashi; M Takahashi; K Maeda; K Kotani; T Nakamura; S Yamashita; M Miura; Y Fukuda; K Takemura; K Tokunaga; Y Matsuzawa
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

4.  Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Yoshihisa Okamoto; Shinji Kihara; Noriyuki Ouchi; Makoto Nishida; Yukio Arita; Masahiro Kumada; Koji Ohashi; Naohiko Sakai; Iichiro Shimomura; Hideki Kobayashi; Naoki Terasaka; Toshimori Inaba; Tohru Funahashi; Yuji Matsuzawa
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

5.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

Authors:  I Shimomura; R E Hammer; S Ikemoto; M S Brown; J L Goldstein
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

6.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.

Authors:  N Ouchi; S Kihara; Y Arita; K Maeda; H Kuriyama; Y Okamoto; K Hotta; M Nishida; M Takahashi; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

7.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

Authors:  K T Uysal; S M Wiesbrock; M W Marino; G S Hotamisligil
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

Review 8.  Adiponectin and metabolic syndrome.

Authors:  Yuji Matsuzawa; Tohru Funahashi; Shinji Kihara; Iichiro Shimomura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

9.  Adiponectin and development of type 2 diabetes in the Pima Indian population.

Authors:  Robert S Lindsay; Tohru Funahashi; Robert L Hanson; Yuji Matsuzawa; Sachiyo Tanaka; P Antonio Tataranni; William C Knowler; Jonathan Krakoff
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

10.  Association of hypoadiponectinemia with coronary artery disease in men.

Authors:  Masahiro Kumada; Shinji Kihara; Satoru Sumitsuji; Toshiharu Kawamoto; Satoru Matsumoto; Noriyuki Ouchi; Yukio Arita; Yoshihisa Okamoto; Iichiro Shimomura; Hisatoyo Hiraoka; Tadashi Nakamura; Tohru Funahashi; Yuji Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-01       Impact factor: 8.311

  10 in total
  11 in total

1.  Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.

Authors:  Daniel Antonio de Luis; Rocío Aller; B de la Fuente; D Primo; Rosa Conde; Olatz Izaola; Manuel Gonzalez Sagrado
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

Review 2.  The good fat hormone: adiponectin and cardiovascular disease.

Authors:  Dat Do; Jorge Alvarez; Elaine Chiquette; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

3.  The serum profile of adipokines in naïve patients with diabetes mellitus type 2 and obesity.

Authors:  D A de Luis; R Aller; O Izaola; H F Ovalle
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

4.  Cardiovascular risk factors and adipocytokines levels after two hypocaloric diets with different fat distribution in obese subjects and rs6923761 gene variant of glucagon-like peptide 1 receptor.

Authors:  Daniel Antonio de Luis; Rocío Aller; Olatz Izaola; R Bachiller; D Pacheco
Journal:  J Endocrinol Invest       Date:  2014-06-27       Impact factor: 4.256

Review 5.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.

Authors:  Harold Bays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

6.  Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients.

Authors:  D A de Luis; R Aller; O Izaola; M Gonzalez Sagrado; R Conde
Journal:  J Endocrinol Invest       Date:  2013-06       Impact factor: 4.256

7.  Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients.

Authors:  D A de Luis; M Gonzalez Sagrado; R Aller; O Izaola; R Conde; Enrique Romero
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

8.  Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients.

Authors:  D A de Luis; R Aller; O Izaola; R Bachiller
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

9.  Effect of rs6923761 gene variant of glucagon-like peptide 1 receptor on metabolic response and weight loss after a 3-month intervention with a hypocaloric diet.

Authors:  Daniel Antonio de Luis; Rocío Aller; Olatz Izaola; J J Lopez; E Gomez; B Torres; G Diaz Soto
Journal:  J Endocrinol Invest       Date:  2014-06-28       Impact factor: 4.256

10.  Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.

Authors:  Rocio Aller; Daniel A de Luis; Luis Fernandez; Fernando Calle; Benito Velayos; Jose Luis Olcoz; Olatz Izaola; Manuel Gonzalez Sagrado; Rosa Conde; Jose Manuel Gonzalez
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.